UNITED STATES
FORM 8-K
CURRENT REPORT
Date of Report (Date of earliest event reported): April 29, 2003
IntraBiotics Pharmaceuticals, Inc.
| Delaware (State or other jurisdiction of incorporation) |
000-29993 (Commission File Number) |
94-3200380 (IRS Employer Identification No.) |
| 2483 East Bayshore Road, Suite 100, Palo Alto, California (Address of principal executive offices) |
94303
(Zip Code) |
Registrant’s telephone number, including area code: (650) 526-6800
Not Applicable
| Item 7. | Financial Statements, Pro Forma Financial Information and Exhibits. |
| (c) | Exhibits |
| Number | Description | |
| 99.1 | Press Release entitled “IntraBiotics Reports First Quarter 2003 Financial and Operating Results,” dated April 29, 2003. |
| Item 9. | Regulation FD Disclosure (Information Provided under Item 12, Disclosure of Results of Operations and Financial Condition). |
Pursuant to the Securities and Exchange Commission Release No. 33-8216, dated March 27, 2003, the information provided herein is being furnished under Item 12 of Form 8-K.
On April 29, 2003, IntraBiotics publicly disseminated a press release announcing certain financial results for the quarter ended March 31, 2003. A copy of the press release with respect to this matter is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TELIK, INC. | ||
| Date: April 29, 2003 |
/s/ Eric H. Bjerkholt Eric H. Bjerkholt Sr. Vice President and Chief Financial Officer |
EXHIBIT INDEX
| Number | Description | |
| 99.1 | Press Release entitled “IntraBiotics Reports First Quarter 2003 Financial and Operating Results,” dated April 29, 2003. |